Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
DJM is supported by a National Health and Medical Research Council senior research fellowship
Menter A, Cram DL
Black Box Warning GLP-1 receptor agonists are contraindicated in individuals with: A history of medullary thyroid carcinoma (MTC), A family history of MTC, or Multiple endocrine neoplasia syndrome type 2 (MEN2)
Compliance: This product is sold strictly for research purposes only
Although a direct causal link between NAD+ supplementation and cancer progression has not been proven, experts recommend that patients with an ongoing cancer or a history of cancer only consider NAD+ therapy with clearance from their oncologist
US$ 25.75
US$ 27.11
US$ 20.60
US$ 29.92
